{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:38:27Z","timestamp":1789540707958,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.josat.2023.208960","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T04:03:58Z","timestamp":1674705838000},"page":"208960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Racial\/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds"],"prefix":"10.1016","volume":"148","author":[{"given":"Panagiota","family":"Kitsantas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman M.","family":"Aljoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley M.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora","family":"Peppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeung Mi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.208960_bb0005","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711: Opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"10.1016\/j.josat.2023.208960_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","article-title":"A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women","volume":"26","author":"Angelotta","year":"2016","journal-title":"Women\u2019s Health Issues"},{"issue":"1","key":"10.1016\/j.josat.2023.208960_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication treatment of opioid use disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.josat.2023.208960_bb0020","series-title":"Treatment Improvement Protocol (TIP) Series 43","article-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs (HHS Publication No. (SMA) 12-4214","year":"2005"},{"key":"10.1016\/j.josat.2023.208960_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: Motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.208960_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","article-title":"Trends in pregnancy-associated mortality involving opioids in the United States, 2007\u20132016","volume":"220","author":"Gemmill","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1016\/j.josat.2023.208960_bb0035","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/1475-6773.12031","article-title":"Disparities in completion of substance abuse treatment between and within racial and ethnic groups","volume":"48","author":"Guerrero","year":"2013","journal-title":"Health Services Research"},{"issue":"11","key":"10.1016\/j.josat.2023.208960_bb0040","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatrics"},{"issue":"3","key":"10.1016\/j.josat.2023.208960_bb0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"2","key":"10.1016\/j.josat.2023.208960_bb0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010\u20132017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.josat.2023.208960_bb0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/ADM.0000000000000780","article-title":"Healthcare patterns of pregnant women and children affected by OUD in 9 state medicaid populations","volume":"15","author":"Jarlenski","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.208960_bb0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1377\/hlthaff.2020.01251","article-title":"Medicaid expansion increased medications for opioid use disorder among adults referred by criminal justice agencies","volume":"40","author":"Khatri","year":"2021","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2023.208960_bb0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.addbeh.2018.11.019","article-title":"Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database","volume":"90","author":"Kozhimannil","year":"2019","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.josat.2023.208960_bb0070","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.josat.2023.208960_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.drugalcdep.2017.06.009","article-title":"Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. National sample","volume":"178","author":"Krawczyk","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.josat.2023.208960_bb0080","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.josat.2023.208960_bb0085","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"issue":"9","key":"10.1016\/j.josat.2023.208960_bb0090","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2023.208960_bb0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/pds.4647","article-title":"Adherence trajectories of buprenorphine therapy among pregnant women in a large state medicaid program in the United States","volume":"28","author":"Lo-Ciganic","year":"2019","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"10.1016\/j.josat.2023.208960_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.208960_bb0105","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.208960_bb0110","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.208960_bb0115","doi-asserted-by":"crossref","first-page":"56S","DOI":"10.1097\/01.AOG.0000663364.06637.15","article-title":"Opioid use disorder: A poorly understood cause of maternal mortality in the United States [26E]","volume":"135","author":"Mitra","year":"2020","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.josat.2023.208960_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108717","article-title":"Opioid use disorder treatment for people experiencing homelessness: A scoping review","volume":"224","author":"McLaughlin","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.208960_bb0125","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences","year":"2019"},{"issue":"4","key":"10.1016\/j.josat.2023.208960_bb0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/AOG.0000000000004307","article-title":"Predictors of initiation of medication for opioid use disorder and retention in treatment among U.S. Pregnant women, 2013\u20132017","volume":"137","author":"Nguemeni Tiako","year":"2021","journal-title":"Obstetrics & Gynecology"},{"issue":"10","key":"10.1016\/j.josat.2023.208960_bb0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jogc.2017.04.028","article-title":"No. 349-substance use in pregnancy","volume":"39","author":"Ordean","year":"2017","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"issue":"12","key":"10.1016\/j.josat.2023.208960_bb0140","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2105\/AJPH.2020.305888","article-title":"Racial and ethnic disparities in maternal and infant outcomes among opioid-exposed mother\u2013infant dyads in Massachusetts (2017\u20132019)","volume":"110","author":"Peeler","year":"2020","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.208960_bb0145","article-title":"Access to medications for opioid use disorder and associated factors among adolescents and young adults: A systematic review","author":"Pilarinos","year":"2021","journal-title":"JAMA Pediatrics"},{"issue":"4","key":"10.1016\/j.josat.2023.208960_bb0150","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.josat.2023.208960_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/002204260603600103","article-title":"Barriers to engaging and retaining african- american post-partum women in drug treatment","volume":"36","author":"Roberts","year":"2006","journal-title":"Journal of Drug Issues"},{"issue":"4","key":"10.1016\/j.josat.2023.208960_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.10.055","article-title":"Drug use and limited prenatal care: An examination of responsible barriers","volume":"200","author":"Schempf","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/j.josat.2023.208960_bb0165","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.208960_bb0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2018.04.003","article-title":"Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States","volume":"89","author":"Short","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.208960_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.06.006","article-title":"Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?","volume":"190","author":"Stahler","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.208960_bb0180","series-title":"Substance Abuse and Mental Health Services Administration (US)","year":"2009"},{"key":"10.1016\/j.josat.2023.208960_bb0185","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2023.208960_bb0190","unstructured":"Substance Abuse and Mental Health Data Archive, n.d. Substance Abuse and Mental Health Data Archive (n.d.). Treatment episode data set: discharges (TEDS-D). Accessed April 10, 2022. https:\/\/www.datafiles.samhsa.gov\/study-series\/treatment-episode-data-set-discharges-teds-d-nid13520."},{"issue":"5","key":"10.1016\/j.josat.2023.208960_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003119","article-title":"Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after medicaid expansion: A retrospective study of admissions to treatment centers in the United States","volume":"17","author":"Winkelman","year":"2020","journal-title":"PLoS Medicine"},{"issue":"12","key":"10.1016\/j.josat.2023.208960_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226349","article-title":"Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014\u201317","volume":"14","author":"Yang","year":"2019","journal-title":"PLoS ONE"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:50:17Z","timestamp":1757433017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":40,"alternative-id":["S2949875923000103"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.208960","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial\/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.208960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"208960"}}